A multidisciplinary team approach minimises prophylactic mastectomy rates

European Journal of Surgical Oncology

Volumn 41, Issue 8, 2015, Pages 1005-1012

  Leff, D R ^a   Ho, C ^a   Thomas, H ^a   Daniels, R ^a   Side, L ^c   Lambert, F ^f   Knight, J ^e   Griffiths, M ^b   Banwell, M ^b   Aitken, J ^d   Clayton, G ^a   Dua, S ^a   Shaw, A ^b   Smith, S ^a   Ramakrishnan, V ^b  

^a BROOMFIELD HOSPITAL   (United Kingdom)

^b St Andrews Centre for Plastic Surgery and Burns   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d WEST SUFFOLK HOSPITAL   (United Kingdom)

^e Breast Reconstruction Awareness Group   (United Kingdom)

^f NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

Breast cancer; Contralateral; Mastectomy; Multidisciplinary; Prophylactic; Risk reducing

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL DECISION MAKING; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; DEPRESSION; FAMILY HISTORY; FEMALE; GENE MUTATION; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTIDISCIPLINARY TEAM; OBSERVATIONAL STUDY; PLASTIC SURGERY; PRIORITY JOURNAL; PROPHYLACTIC MASTECTOMY; PROPHYLACTIC SURGICAL PROCEDURE; RETROSPECTIVE STUDY; BREAST NEOPLASMS; DECISION MAKING; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE; UTILIZATION;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MASTECTOMY; PATIENT CARE TEAM; RETROSPECTIVE STUDIES;

EID: 84943405997     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.02.017     Document Type: Article

References (46)

1. T.M. Tuttle, A. Abbott, A. Arrington, and N. Rueth The increasing use of prophylactic mastectomy in the prevention of breast cancer Curr Oncol Rep 12 2010 16 21
2. T.M. Tuttle, E.B. Habermann, E.H. Grund, T.J. Morris, and B.A. Virnig Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment J Clin Oncol 25 2007 5203 5209
3. C.C. McLaughlin, P.P. Lillquist, and S.B. Edge Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005 Cancer 115 2009 5404 5412
4. A.K. Arrington, S.L. Jarosek, B.A. Virnig, E.B. Habermann, and T.M. Tuttle Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer Ann Surg Oncol 16 2009 2697 2704
5. N.B. Jones, J. Wilson, L. Kotur, J. Stephens, W.B. Farrar, and D.M. Agnese Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution Ann Surg Oncol 16 2009 2691 2696
6. K. Yao, A.K. Stewart, D.J. Winchester, and D.P. Winchester Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007 Ann Surg Oncol 17 2010 2554 2562
7. C.C. Stucky, R.J. Gray, N. Wasif, A.C. Dueck, and B.A. Pockaj Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer Annals of surgical oncology 17 3 2010 330 337
8. T.A. King, R. Sakr, S. Patil, I. Gurevich, and et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy J Clin Oncol 29 2011 2158 2164
9. M. Yi, K.K. Hunt, B.K. Arun, and et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy Cancer Prev Res 3 2010 1026 1034
10. Tamoxifen Alone or in Combination Trialists' Group, J.F. Forbes, J. Cuzick, and et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Lancet Oncol 9 2008 45 53
11. Early Breast Cancer Trialists' Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
12. U. Guth, M.E. Myrick, C.T. Viehl, and et al. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA? Eur J Surg Oncol 38 2012 296 301
13. J. Neuburger, F. Macneill, R. Jeevan, and et al. Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics BMJ Open 3 8 2013 Aug 1 pii: e003179
14. A.S. Reiner, E.M. John, J.D. Brooks, and et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study J Clin Oncol 31 2013 433 439
15. L.J. Herrinton, W.E. Barlow, O. Yu, and et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project J Clin Oncol 23 2005 4275 4286
16. A.M. Brewster, I. Bedrosian, P.A. Parker, and et al. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status Cancer 118 2012 5637 5643
17. I. Bedrosian, I. Bedrosian, P.A. Parker, and et al. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients J Natl Cancer Inst 102 2010 401 409
18. Prophylactic mastectomy for the prevention of breast cancer Cochrane Database Syst Rev 2010 CD002748
19. O.M. Fayanju, C.R. Stoll, S. Fowler, and et al. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis Ann Surg 260 6 2014 Dec 1000 1010 10.1097/SLA.0000000000000769
20. L. Kruper, R.M. Kauffmann, D.D. Smith, and et al. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias Ann Surg Oncol 21 11 2014 Oct 3448 3456 10.1245/s10434-014-3930-0 Epub 2014 Jul 22
21. T.C. van Sprundel, M.K. Schmidt, M.A. Rookus, and et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers Br J cancer 93 2005 287 292
22. J.C. Boughey, T.L. Hoskin, A.C. Degnim, and et al. Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer Ann Surg Oncol 17 2010 2702 2709
23. E.A. Peralta, J.D. Ellenhorn, L.D. Wagman, and et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer Am J Surg 180 2000 439 445
24. A. Soran, A. Ibrahim, M. Kanbour, and et al. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast Cancer Am J Clin Oncol 38 2 2015 Apr 179 183 10.1097/COC.0b013e318292f8a7
25. S.M. Rosenberg, M.S. Tracy, M. Meyer, and et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey Ann Intern Med 159 2013 373 381
26. A.A. Deshmukh, S.B. Cantor, M.A. Crosby, and et al. Cost of contralateral prophylactic mastectomy Ann Surg Oncol 21 2014 2823 2830
27. A. Roberts, M. Habibi, and K.D. Frick Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer Ann Surg Oncol 21 2014 2209 2217
28. X.A. Pinell-White, K. Kolegraff, and G.W. Carlson Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction Ann Plastic Surg 72 2014 S153 S157
29. M.B. Barton, C.N. West, I.L. Liu, and et al. Complications following bilateral prophylactic mastectomy J Natl Cancer Inst Monogr 2005 61 66
30. K. Goldflam, K.K. Hunt, and J.E. Gershenwald Contralateral prophylactic mastectomy. Predictors of significant histologic findings Cancer 101 2004 1977 1986
31. M.A. Crosby, P.B. Garvey, J.C. Selber, and et al. Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy Plastic Reconstr Surg 128 2011 1025 1033
32. M.E. Miller, T. Czechura, B. Martz, and et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience Ann Surg Oncol 20 2013 4113 4120
33. I. Bedrosian, and K. Yao Contralateral prophylactic mastectomy and survival: an ongoing Challenge Ann Surg Oncol 21 11 2014 Oct 3372 3374 10.1245/s10434-014-3938-5 Epub 2014 Jul 22
34. S.J. Katz, and M. Morrow Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind JAMA 310 2013 793 794
35. F. Lalloo, A. Baildam, A. Brain, and et al. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer Eur J Surg Oncol 26 2000 711 713
36. P.L. Mai, V.I. Lagos, M.R. Palomares, and J.N. Weitzel Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment Ann Surg Oncol 15 2008 3415 3421
37. National Insitute for Health and Care Excellence. Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. [Available at: http://www.nice.org.uk/guidance/cg164/resources/cg164-familial-breast-cancer-full-guideline3 [accessed 7.08.14].
38. G.C. Wishart, C.D. Bajdik, E. Dicks, and et al. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 Br J cancer 107 2012 800 807
39. A. Abbott, N. Rueth, S. Pappas-Varco, and et al. Perceptions of contralateral breast cancer: an overestimation of risk Ann Surg Oncol 18 2011 3129 3136
40. J. Kollias, I.O. Ellis, C.W. Elston, and R.W. Blamey Clinical and histological predictors of contralateral breast cancer Eur J Surg Oncol 25 1999 584 589
41. T. Saphner, D.C. Tormey, and R. Gray Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 14 1996 2738 2746
42. J. Cuzick, I. Sestak, M. Baum, and et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Lancet Oncol 11 2010 1135 1141
43. K. Metcalfe, H.T. Lynch, P. Ghadirian, and et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2004 2328 2335
44. H.B. Nichols, A. Berrington de González, J.V. Lacey Jr., and et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006 J Clin Oncol 29 2011 1564 1569
45. J.L. Bernstein, B. Langholz, R.W. Haile, and et al. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study Breast cancer Res 6 2004 R199 R214
46. M.H. Frost, T.L. Hoskin, L.C. Hartmann, and et al. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits Ann Surg Oncol 18 2011 3110 3116